163 related articles for article (PubMed ID: 9297069)
1. [Steroid-induced myopathy in left-sided ulcerative colitis. Successful treatment and continued therapy with the topical steroid budesonide].
Caesar I; Gross V; Roth M; Andus T; Hohenberger W; Schölmerich J
Med Klin (Munich); 1997 Jun; 92(6):358-62. PubMed ID: 9297069
[TBL] [Abstract][Full Text] [Related]
2. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group.
Scand J Gastroenterol; 1991 Dec; 26(12):1225-30. PubMed ID: 1763292
[TBL] [Abstract][Full Text] [Related]
3. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.
Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L
Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395
[TBL] [Abstract][Full Text] [Related]
4. [Locally acting glucocorticoids in chronic intestinal inflammation].
Lamers CB; van der Sluys Veer A; Wagtmans MJ; van Hogezand RA
Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2533-5. PubMed ID: 7830800
[No Abstract] [Full Text] [Related]
5. Oral budesonide therapy for ulcerative colitis: a topical tale.
Feagan BG
Gastroenterology; 1996 Jun; 110(6):2000-2. PubMed ID: 8964430
[No Abstract] [Full Text] [Related]
6. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
Naganuma M; Aoyama N; Tada T; Kobayashi K; Hirai F; Watanabe K; Watanabe M; Hibi T
J Gastroenterol; 2018 Apr; 53(4):494-506. PubMed ID: 28779419
[TBL] [Abstract][Full Text] [Related]
7. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide therapy for steroid-dependent ulcerative colitis: a pilot trial.
Keller R; Stoll R; Foerster EC; Gutsche N; Domschke W
Aliment Pharmacol Ther; 1997 Dec; 11(6):1047-52. PubMed ID: 9663828
[TBL] [Abstract][Full Text] [Related]
9. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E
Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968
[TBL] [Abstract][Full Text] [Related]
10. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
Löfberg R; Ostergaard Thomsen O; Langholz E; Schiöler R; Danielsson A; Suhr O; Graffner H; Påhlman L; Matzen P; Møller-Petersen JF
Aliment Pharmacol Ther; 1994 Dec; 8(6):623-9. PubMed ID: 7696452
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
[TBL] [Abstract][Full Text] [Related]
12. The new steroids: clinical experience in ulcerative colitis.
Jewell DP
Mt Sinai J Med; 1990 Oct; 57(5):293-6. PubMed ID: 1710774
[No Abstract] [Full Text] [Related]
13. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
[TBL] [Abstract][Full Text] [Related]
14. Topical therapy is underused in patients with ulcerative colitis.
Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
[TBL] [Abstract][Full Text] [Related]
15. Budesonide in inflammatory bowel disease.
Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
[TBL] [Abstract][Full Text] [Related]
16. Controlled-release budesonide in Crohn's disease.
Drug Ther Bull; 1997 Apr; 35(4):30-1. PubMed ID: 9282408
[TBL] [Abstract][Full Text] [Related]
17. Budesonide multi-matrix system formulation for treating ulcerative colitis.
Prantera C; Scribano ML
Expert Opin Pharmacother; 2014 Apr; 15(6):741-3. PubMed ID: 24484392
[TBL] [Abstract][Full Text] [Related]
18. Variability of the symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome during intermittent therapy with rectal prednisolone foam for ulcerative colitis.
Talbot M; Bates S
Int J STD AIDS; 2001 Nov; 12(11):752-3. PubMed ID: 11589817
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis.
Danielsson A; Edsbäcker S; Löfberg R; Nilsson A; Nyman-Pantelidis M; Olsson O; Suhr O; Willén R
Aliment Pharmacol Ther; 1993 Aug; 7(4):401-7. PubMed ID: 8218754
[TBL] [Abstract][Full Text] [Related]
20. [Topical steroids in chronic inflammatory bowel diseases].
Fleig WE
Internist (Berl); 1997 Dec; 38(12):1154-9. PubMed ID: 9465320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
